| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/11/2000 | WO2000006124A3 A novel excipient for the lyophilization of aqueous suspensions of microparticles |
| 05/11/2000 | CA2349158A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | CA2348536A1 Radiodense compositions |
| 05/11/2000 | CA2348475A1 Tuberculosis diagnostic test |
| 05/11/2000 | CA2348094A1 Method for improved imaging and photodynamic therapy |
| 05/11/2000 | CA2348032A1 Hyperpolarized helium-3 microbubble gas entrapment methods |
| 05/11/2000 | CA2347915A1 Enhanced radiation therapy |
| 05/10/2000 | EP0999280A2 Episomally replicating vector, its preparation and use |
| 05/10/2000 | EP0998946A1 Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical |
| 05/10/2000 | EP0998674A2 Conjugate for differentiating between healthy and unhealthy tissue |
| 05/10/2000 | EP0998476A1 1,4,7,10-tetraazabicyclo 8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles |
| 05/10/2000 | EP0998308A2 Diagnostic method for the detection of miocardial ischemia |
| 05/10/2000 | EP0998267A1 Internally supported lipid vesicle systems |
| 05/10/2000 | EP0707624B1 Perfluoro-1h-1h-neopentyl containing contrast agents and method to use same |
| 05/09/2000 | US6060614 Chelating ligands having a tripodal backbone |
| 05/09/2000 | US6060598 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding |
| 05/09/2000 | US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle |
| 05/09/2000 | US6060057 Cloning and sequencing of allergens of Dermatophagoides (house dust mite) |
| 05/09/2000 | US6060040 Paramagnetic metal chelates of novel acrylic compounds |
| 05/09/2000 | CA2058940C Targeted liposomes and methods for liposome-protein coupling |
| 05/04/2000 | WO2000024875A1 Compositions and methods useful for treatment of depressive disorder based on an animal model |
| 05/04/2000 | WO2000024429A2 Compound |
| 05/04/2000 | WO2000024315A1 Real time optoacoustic monitoring of changes in tissue properties |
| 05/04/2000 | WO2000004868A3 Libraries of polyhydroxamates and their analogs |
| 05/04/2000 | WO1999066036A9 Transplants for myocardial scars |
| 05/03/2000 | EP0996470A1 Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases |
| 05/03/2000 | EP0996469A1 Methods of photoacoustic imaging |
| 05/03/2000 | EP0625055B1 Use of fullerenes in diagnostic and/or therapeutic agents |
| 05/03/2000 | EP0562119B1 Medicated syringe preparation |
| 05/03/2000 | EP0560947B1 Trivalent monospecific antigen binding proteins |
| 05/03/2000 | CN1252051A Contrast agent preparation |
| 05/02/2000 | US6057490 Evaluating expression of reporter gene under regulation of systemic acquired resistance gene promoter in uninfected, phenotypically normal plants, and selecting plants that constitutively express gene in absence of infections |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057419 Drugs and images |
| 05/02/2000 | US6057298 Administering to treat skin cancer |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | US6056943 Methods of ultrasound imaging using phospholipid stabilized microbubbles |
| 05/02/2000 | US6056939 Self-assembling heteropolymetallic chelates as imaging agents and radiopharmaceuticals |
| 04/27/2000 | WO2000023797A1 Bulk production and usage of hyperpolarized 129xenon |
| 04/27/2000 | WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 04/27/2000 | WO2000023111A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023108A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000000636A3 In vivo determination of metabolic function for use in therapy management |
| 04/27/2000 | WO1999066255A3 Resilient containers for hyperpolarized gases |
| 04/27/2000 | WO1999059545A9 Targeted liposomal drug delivery system |
| 04/27/2000 | WO1998048838A8 Compounds |
| 04/27/2000 | DE19849465A1 New dimeric ion pairs containing cationic and anionic metal complexes; useful as low viscosity contrast agents for X-ray, magnetic resonance and radiodiagnostic techniques, and as radiotherapy agents |
| 04/27/2000 | CA2347085A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2347081A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/26/2000 | EP0995761A2 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 04/26/2000 | EP0995740A1 Novel nitroxyl compounds and drugs and reagents containing the same as the active ingredient |
| 04/26/2000 | EP0995448A1 Diagnostic agents and remedies for malignant tumors |
| 04/26/2000 | EP0994730A2 LABELLED FACTOR XIIIa SUBSTRATES |
| 04/26/2000 | EP0994729A1 Use of intravenous contrast agents and devices for projection mammography |
| 04/26/2000 | EP0883808B1 Process for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and use thereof |
| 04/26/2000 | EP0579802B1 Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents |
| 04/25/2000 | US6054633 Live mouse mutagenesis systems for testing mutagenic agents in vivo |
| 04/25/2000 | US6054125 Purified mite allergen |
| 04/25/2000 | US6054118 Contrast agents comprising two types of gas-containing microparticles |
| 04/25/2000 | US6054117 Nuclear magnetic resonance contrast media for diagnostics and therapy; physiologically acceptable excretion |
| 04/25/2000 | US6054114 Diagnosing the degree of progression of alzheimer's disease in a mammal, monitoring the response to a therapy in a mammal having alzheimer's disease, identifying an agent useful for treating alzheimer's disease |
| 04/20/2000 | WO2000021578A1 Novel ultrasound contrast agents |
| 04/20/2000 | WO2000021577A2 Compositions |
| 04/20/2000 | WO2000021576A2 Method for viewing tumor tissue located within a body cavity |
| 04/20/2000 | WO2000021560A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 04/20/2000 | WO2000021505A2 Composition for the parenteral administration of active agents |
| 04/20/2000 | DE19848017A1 Episomally replicating vectors, useful in gene therapy, contain origins of replication and scaffold-matrix attached region sequences but no viral coding sequences |
| 04/20/2000 | DE19847593A1 Parenteral drug administration composition with depot and controlled release comprises active agent and water soluble polysaccharide microparticles as carrier |
| 04/20/2000 | CA2347461A1 Method for viewing tumor tissue located within a body cavity |
| 04/20/2000 | CA2346670A1 Composition for the parenteral administration of active compounds |
| 04/20/2000 | CA2345458A1 Novel ultrasound contrast agents |
| 04/19/2000 | EP0994352A2 Contrast agent enhanced magnetic resonance imaging of myocardial tissue |
| 04/19/2000 | EP0993306A1 Perfluoroalkylated oligomer compounds, process for preparing the same and their use in nmr diagnosis |
| 04/18/2000 | US6051607 Vascular embolizing compositions comprising ethyl lactate and methods for their use |
| 04/18/2000 | US6051555 Administering a peptide |
| 04/18/2000 | US6051429 Peptide-enhanced cationic lipid transfections |
| 04/18/2000 | US6051230 For treatment and/or diagnosis (imaging) of vascularized solid tumors |
| 04/18/2000 | US6051210 Biologically injecting |
| 04/18/2000 | US6051208 In vivo magnetic resonance vascular imaging using laser-polarized gas microbubbles |
| 04/18/2000 | US6051207 Phosphatidylserine linked isoxazole sulfonamide derivatives; diagnosing and imaging cardiovascular disorders |
| 04/18/2000 | CA2069485C Delayed release formulations |
| 04/17/2000 | CA2284849A1 Episomally replicating vector, its preparation and use |
| 04/13/2000 | WO2000020640A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/13/2000 | WO2000020625A1 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
| 04/13/2000 | WO2000020044A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 04/13/2000 | WO2000020043A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 04/13/2000 | WO2000020042A2 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 04/13/2000 | WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | WO2000019823A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof |
| 04/13/2000 | WO1999061072A3 Methods of inhibiting clot formation |
| 04/13/2000 | WO1999055387A8 Methods for detecting lesions in dense breast tissue using lhrh antagonists |
| 04/13/2000 | WO1999038500A3 The human calcium-sensing receptor in the detection and treatment of cancer |
| 04/13/2000 | WO1999035241A9 Transgenic rabbit that expresses a functional human lipoprotein (a) |
| 04/13/2000 | CA2346695A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof |
| 04/13/2000 | CA2346459A1 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
| 04/13/2000 | CA2346326A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 04/13/2000 | CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | CA2345285A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 04/13/2000 | CA2345000A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/12/2000 | EP0992245A1 Radio-contrast agents |